Market price of Glivec disputed

Published: 2002-04-22 06:57:00

Updated: 2002-04-22 06:57:00

The Joint Countermeasure Committee for making Glivec available to Korean patients with chronic myeloid leukemia (CML) has recently urged that the government should forcibly enforce the public price of Glivec at the price of 17,862 won/tab., since the CML patients cannot gain access to the drug in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK